...
首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Quantitation of five nevirapine oxidative metabolites in human plasma using liquid chromatography-tandem mass spectrometry
【24h】

Quantitation of five nevirapine oxidative metabolites in human plasma using liquid chromatography-tandem mass spectrometry

机译:液相色谱-串联质谱法定量测定人血浆中的五种奈韦拉平氧化代谢产物

获取原文
获取原文并翻译 | 示例

摘要

A multiple-reaction-monitoring LC/MS/MS method for the analysis of nevirapine oxidative metabolites, 2-hydroxynevirapine, 3-hydroxynevirapine, 8-hydroxynevirapine, 12-hydroxynevirapine, and 4-carboxynevirapine, in human plasma was developed and validated. The metabolites were isolated from 50 mu L heparinized plasma by enzymatic hydrolysis of the glucuronide conjugates to the free metabolite followed by protein precipitation with acetonitrile. Peaks were quantitated at 3.03 min for the 4-carboxynevirapine metabolite, at 3.72, 4.27, 5.27, and 5.73 min for the positional 2-hydroxynevirapine, 12-hydroxynevirapine, 3-hydroxynevirapine, and 8-hydroxynevirapine metabolites, respectively, and 2.30 min for the internal standard, pirenzepine. The assay was accurate and precise based on assay validation controls over the nominal range of 0.010-1.0 mg/L. The average accuracy at the lowest concentration quality control (QC) sample was 16% (difference from theoretical value) for 8-hydroxynevirapine, all others were closer to their known respective standards. Within- and between-day precisions were within 12% for quality control samples for all five metabolites. Repetitive thawing and freezing did not have an effect on any metabolite through a minimum of three cycles. Thawed samples, remaining in plasma for 4 It before extraction, were within 5% of theoretical value. Stability of the extracted samples on the autosampler at room temperature was evaluated for 48 h and was observed to be within 12% of a fresh analytical sample for 2-hydroxynevirapine and 3-hydroxynevirapine; other metabolites were within 6% of theoretical value. The utility of the analytical method was demonstrated using trough steady-state plasma samples collected from 48 patients in a hepatic impairment study. (C) 2007 Elsevier B.V. All rights reserved.
机译:建立并验证了用于监测人血浆中奈韦拉平氧化代谢产物,2-羟基奈韦拉平,3-羟基奈韦拉平,8-羟基奈韦拉平,12-羟基奈韦拉平和4-羧基奈韦拉平的多反应监测LC / MS / MS方法。通过将葡糖醛酸苷结合物酶解为游离代谢物,然后用乙腈进行蛋白质沉淀,从50μL肝素化血浆中分离出代谢物。 4-羧基nevirapine代谢产物的峰分别在3.03分钟处定量,位置2-羟基nevirapine,12-羟基nevirapine,3-羟基nevirapine和8-羟基nevirapine代谢物的峰分别在3.72、4.27、5.27和5.73 min处定量,内标哌仑西平。基于0.010-1.0 mg / L标称范围内的分析验证对照,该分析准确而精确。最低浓度质量控制(QC)样品的8-羟基奈韦拉平平均准确度为16%(与理论值相差),所有其他均更接近各自的已知标准。所有五个代谢物的质量控制样品的日内和日间精度均在12%以内。反复融化和冷冻至少三个周期对任何代谢物都没有影响。解冻后的样品在提取前在血浆中保留4 It的融化样品在理论值的5%以内。在室温下,在自动进样器上对提取样品的稳定性进行了48小时的评估,观察到其在新鲜的2-羟基奈韦拉平和3-羟基奈韦拉平分析样品的12%范围内。其他代谢物均在理论值的6%以内。在肝功能不全研究中,使用了从48例患者中收集的低谷稳态血浆样品,证明了该分析方法的实用性。 (C)2007 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号